CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia

Affiliations

• ¹ Clinical Laboratory and Department of Hematology, University Hospital La Fe, Valencia, Spain barragan_eva@gva.es.
• ² Department of Hematology, University Hospital of Salamanca, Salamanca Institute for Biomedical Research (IBSAL), Spain.
• ³ Program of Hematology-Oncology, CIMA, University of Navarra, Pamplona, Spain.
• ⁴ Department of Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
• ⁵ Clinical Laboratory and Department of Hematology, University Hospital La Fe, Valencia, Spain.
• ⁶ Department of Hematology, Gregorio Marañón Institute for Health Research, Madrid, Spain.
• ⁷ Department of Hematology, Clinical University of Navarra, Pamplona, Spain.
• ⁸ Department of Biochemistry and Genetics, University of Navarra, Pamplona, Spain.
• ⁹ Program of Hematology-Oncology, CIMA, University of Navarra, Pamplona, Spain Department of Biochemistry and Genetics, University of Navarra, Pamplona, Spain.